Vilem Guryca

AVILiQ Basel, Managing director Consultancy and analyses of business development opportunities. ROCHE Basel, Insights manager Performed assessments of early and late-stage as well as commercial business development opportunities, including established products and partnering - leading to over 20 significant R&D late-stage investment initiatives. Authored consultancy reports on pipeline progress for senior management to support portfolio strategies - across major Roche/Genentech therapeutic areas (incl. oncology, neuroscience and cardio-metabolism). Provided accurate insights on product and market environments to ensure advantages for lifecycle teams focused on therapeutic area of early-stage Genentech respiratory diseases. Developed strategic analyses to drive the long-term Pharma business planning process and worked closely with Corporate Finance, Commercial affiliates and Product Strategy functions. ROCHE Basel, Scientist Led Functional Excellence projects utilizing basic science approaches. Responsible for profiling of plasma proteins for biomarker discovery. CEA Grenoble, Scientist Performed research for a section of an EU-collaborative project in Mass spectrometry/Proteomics. Published 5 peer-reviewed articles INDIANA UNIVERSITY, Bloomington Developed stationary phases for separations of glycoprotein molecules and wrote 2 publications. INSTITUTE MACROMOLECULAR CHEMISTRY, Prague, Researcher Developed polymeric materials (biodegradable hydrogels) for technical-medical practice presented in 5 publications.

• MBA LaSalle University, Philadelphia
• PhD Charles University Prague